Time-dependent expression of CD25 in phytohemagglutinin- or interleukin-2-stimulated human peripheral blood lymphocytes

Cell and Tissue Biology

Volumn 3, Issue 4, 2009, Pages 317-322

  Zenin, V V ^a   Aksenov, N D ^a   Shatrova, A N ^a   Marakhova, I I ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

subunit; CD25; Human lymphocytes; Interleukin 2; Interleukin 2 receptor

Indexed keywords

EID: 70349102037     PISSN: 1990519X     EISSN: 19905203     Source Type: Journal    
DOI: 10.1134/S1990519X09040026     Document Type: Article

References (29)

1. Benczik, M. and Gaffen, S.L., The Interleukin (IL)-2 Family Cytokines: Survival and Proliferation Signaling Pathways in T Lymphocytes, Immunol Invest., 2004, vol. 33, pp. 109-142.
2. Bensinger, S.J., Walsh, P.T., Zhang, J., Carroll, M., Parsons, R., Rathmell, J.C., Thompson, C.B., Burchill, M.A., Farrar, M.A., and Turka, L.A., Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells, J. Immunol., 2004, vol. 172, pp. 5287-5296.
3. Berridge, M.J., Lymphocyte Activation in Health and Disease, Crit. Rev. Immunol., 1997, vol. 17, pp. 155-178.
4. Boyum, A., Separation of Leucocytes from Blood and Bone Marrow, J. Clin. Lab. Invest., 1968, vol. 21, pp. 9-29.
5. Burchill, M.A., Yang, J., Vang, K.B., and Farrar, M.A., Interleukin-2 Receptor Signaling in Regulatory T Cell Development and Homeostasis, Immunol. Lett., 2007, vol. 114, pp. 1-8.
6. 2+, Calcineurin, and NF-AT, Cell, 1999, vol. 96, pp. 611-614.
7. Crabtree, G.R. and Clipstone, N.A., Signal Transmission between the Plasma Membrane and Nucleus of T Lymphocytes, Annu. Rev. Biochem., 1994, vol. 63, pp. 1045-1083.
8. Eicher, D.M., Damjanovich, S., and Waldmann, T.A., Oligomerization of IL-2 Ralpha, Cytokine, 2002, vol. 17, pp. 82-90.
9. Ellery, J.M., Kempshall, S.J., and Nicholls, P.J., Activation of the Interleukin 2 Receptor: A Possible Role for Tyrosine Phosphatases, Cell. Signal., 2000, vol. 12, pp. 367-373.
10. Ellery J.M. and Nicholls, P.J., Possible Mechanism for the alpha Subunit of the Interleukin-2 Receptor (CD25) to Influence Interleukin-2 Receptor Signal Transduction, Immunol. Cell Biol., 2002a, vol. 80, pp. 351-359.
11. Ellery, J.M. and Nicholls, P.J., Alternate Signalling from the Interleukin-2 Receptor, Cytokine Growth Factor Rev., 2002b, vol. 13, pp. 27-40.
12. Gaffen, S.L., Signaling Domains of the Inteleukin-2 Receptor, Cytokine, 2001, vol. 14, pp. 63-77.
13. Imbert, V., Rezzonico, R., Reichenbach, P., and Nabholz, M., Induction of Interleukin-2 Receptor alpha (IL-2 Ralpha) Expression by Interleukin-2: Important Role of the Interleukin-2 Receptor beta Chain Region between the Two Stat5 Docking Sites, Eur. Cytokine Netw., 2002, vol. 13, pp. 331-339.
14. Kim, H.P. and Leonard, W.J., The Basis for TCR-Mediated Regulation of the IL-2 Receptor alpha Chain Gene: Role of Widely Separated Regulatory Elements, EMBO J., 2002, vol. 21, pp. 3051-3059.
15. Koon, H.B., Severy, P., Hagg, D.S., Butler, K., Hill, T., Jones, A.G., Waldmann, T.A., and Junghans, R.P., Antileukemic Effect of Daclizumab in CD25 High-Expressing Leukemias and Impact of Tumor Burden on Antibody Dosing, Leuk. Res., 2006, vol. 30, pp. 190-203.
16. Kumagai, N., Benedict, S.H., Mills, G.B., and Gelfand, E.M., Comparison of Phorbol Ester/Calcium Ionophore and Phytohemagglutinin-Induced Signalling in Human T Lymphocytes, J. Immunol., 1988, vol. 140, pp. 37-43.
17. Leonard, W.J. and Lin, J.X., Cytokine Receptor Signaling Pathways, J. Allergy Clin. Immunol., 2000, vol. 105, pp. 877-888.
18. Lin J. and Weiss, A., T Cell Receptor Signaling, J. Cell. Sci., 2001, vol. 114, pp. 243-244.
19. c) Receptor Subunit, J. Biol. Chem., 2003, vol. 278, pp. 10239-102249.
20. Lockyer, H.M., Tran, E., and Nelson, B.H., STAT5 Is Essential for Akt/ p70S6 Kinase Activity during IL-2 Induced Lymphocyte Proliferation, J. Immunol., 2007, vol. 179, pp. 5301-5308.
21. Marakhova, I.I., Karitskaya, I.A., Aksenov, N.D., Zenin, V.V., and Vinogradova, T.A., Interleukin-2-Dependent Regulation of Na/K Pump in Human Lymphocytes, FEBS Lett., 2005, vol. 579, pp. 2773-2780.
22. Nelson, B.H., IL-2, Regulatory T Cells, and Tolerance, J. Immunol., 2004, vol. 172, pp. 3983-3988.
23. Passerini, L., Allan, S.E., Battaglia, M., Di Nunzino, S., Alstad, A.N., Levings, M.K., Roncarolo, M.G., and Bacchetta, R., STAT5-Signalling Cytokines Regulate the Expression of FOXP3 in CD4+CD25+ Regulatory T Cells and CD4+CD25+-Effector T Cells, Int. Immunol., 2008, vol. 20, pp. 421-431.
24. Morris, J.C., Waldmann, T.A., and Janik, J.E., Receptor-Directed Therapy of T-Cell Leukemias and Lymphomas, J. Immunotoxicol., 2008, vol. 5, pp. 235-248.
25. Tkaczuka, J., Yua, C.L., Baksha, S., Milfordb, E.L., Carpenterb, C.B., Burakoffa, S.J., and McKaya, D.B., Effect of Anti-IL-2Ra Antibody on IL-2-Induced Jak/STAT Signaling, Am. J. Transplant., 2002, vol. 2, pp. 31-40.
26. Waldmann, T.A., The Interleukin-2 Receptor, J. Biol. Chem., 1994, vol. 266, pp. 2681-2684.
27. Waldmann, T.A., Daclizumab (anti-Tac, Zenapax) in the Treatment of Leukemia/Lymphoma, Oncogene, 2007, vol. 26, pp. 3699-3703.
28. Zorn, E., Nelson, E.A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R.J., Frank, D.A., and Ritz, J., IL-2 Regulates FOXP3 Expression in Human CD4+CD25+ Regulatory T Cells through a STAT-Dependent Mechanism and Induces the Expansion of These Cells in Vivo, Blood, 2006, vol. 108, pp. 1571-1579.
29. Yao, Z., Kanno, Y., Kerenyi, M., Stephens, G., Durant, L., Watford, W.T., Laurence, A., Robinson, G.W., Shevach, E.M., Moriggl, R., Hennighausen, L., Wu, C., and O'Shea, J.J., Nonredundant Roles for Stat5a/b in Directly Regulating Foxp 3, Blood, 2007, vol. 109, pp. 4368-4375.